Owing to the higher biological grade of HER2‐positive breast cancer and with the treatment goal of OS prolongation, the standard therapy for ER‐positive HER2‐positive AMBC is widely recognized as the combination of chemotherapy and anti‐HER2 therapy.6, 7. The gene discussed is ESR1; the disease is breast carcinoma.